1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014

Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014" provides data on the Papillary Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Papillary Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Papillary Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Papillary Thyroid Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Papillary Thyroid Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Papillary Thyroid Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Papillary Thyroid Cancer 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Papillary Thyroid Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
AstraZeneca PLC 31
Clinical Trial Overview of AstraZeneca PLC 31
Exelixis, Inc. 32
Clinical Trial Overview of Exelixis, Inc. 32
Eisai Co., Ltd. 33
Clinical Trial Overview of Eisai Co., Ltd. 33
Tesaro, Inc. 34
Clinical Trial Overview of Tesaro, Inc. 34
MethylGene Inc. 35
Clinical Trial Overview of MethylGene Inc. 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of Top Institutes / Government 37
National Cancer Institute 37
Clinical Trial Overview of National Cancer Institute 37
Yonsei University 38
Clinical Trial Overview of Yonsei University 38
University of Washington 39
Clinical Trial Overview of University of Washington 39
University of Kentucky 40
Clinical Trial Overview of University of Kentucky 40
Samsung Medical Center 41
Clinical Trial Overview of Samsung Medical Center 41
Memorial Sloan Kettering Cancer Center 42
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 42
University of Colorado 43
Clinical Trial Overview of University of Colorado 43
National Taiwan University Hospital 44
Clinical Trial Overview of National Taiwan University Hospital 44
The National Institute of Diabetes and Digestive and Kidney Diseases 45
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 45
University of Michigan 46
Clinical Trial Overview of University of Michigan 46
Five Key Clinical Profiles 47
Appendix 88
Abbreviations 88
Definitions 88
Research Methodology 89
Secondary Research 89
About GlobalData 90
Contact Us 90
Disclaimer 90
Source 91

List of Tables
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Papillary Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Papillary Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Papillary Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Papillary Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Papillary Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Papillary Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Papillary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Papillary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Papillary Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Papillary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Papillary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Papillary Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Papillary Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 31
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2014* 32
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 33
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tesaro, Inc., 2014* 34
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MethylGene Inc., 2014* 35
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 36
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 37
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 38
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 39
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014* 40
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 41
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 42
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2014* 43
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 44
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 45
Papillary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014* 46

List of Figures
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Papillary Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Papillary Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Papillary Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Papillary Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Papillary Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Papillary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Papillary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Papillary Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Papillary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Papillary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Papillary Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Papillary Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Papillary Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 89

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.